This page is not the official website. Generated by AI, does not constitute any advice. If needed, please click here to visit the corresponding official website.
Changzhou Pharmaceutical Factory (CPF) – a leading Chinese manufacturer of Active Pharmaceutical Ingredients and finished dosage forms since 1949. FDA, EU GMP, and PMDA compliant.
Established in 1949 in Changzhou, Jiangsu Province, CZ Pharma (Changzhou Pharmaceutical Factory) has grown into a major manufacturer of Active Pharmaceutical Ingredients (APIs) and finished formulations.
The company covers an area of 300,000m² and employs over 1,450 staff, including more than 300 specialized technicians. CPF is dedicated to producing high-quality cardiovascular, metabolic, and oncology medicines for global markets.
Square Meters Facility
Employees
We offer a wide range of high-purity APIs and finished formulations across multiple therapeutic areas including cardiovascular, diabetes, oncology, and CNS disorders.
Indication: Type 2 Diabetes, Weight Loss
Innovator: Novo Nordisk | Patent Expiry: Dec. 05, 2031
Indication: Type 2 Diabetes, Weight Loss
Innovator: Eli Lilly | Patent Expiry: Jan. 05, 2036
Indication: NSCLC (Non-Small Cell Lung Cancer)
Innovator: AstraZeneca | Patent Expiry: Aug. 8, 2032
Indication: MCL, CLL, SLL, WM
Innovator: BeiGene | Patent Expiry: Apr. 2034
Indication: NSCLC
Innovator: Roche Pharma AG | Patent Expiry: Jun. 9, 2030
Indication: Melanoma
Innovator: Novartis (GSK R&D) | Patent Expiry: Jul. 20, 2030
Indication: Ulcerative Colitis (UC)
Innovator: Arena (Pfizer) | Patent Expiry: Mar. 05, 2030
Indication: Hypertension
Innovator: Idorsia Pharmaceuticals | Patent Expiry: Sep. 21, 2034
Indication: Type 2 Diabetes
Innovator: Eli Lilly | Patent Expiry: Sep. 26, 2037
Indication: Analgesic
Innovator: Vertex Pharmaceuticals | Patent Expiry: Dec. 4, 2040
Indication: PNH, IgA Nephropathy
Innovator: Novartis | Patent Expiry: Jul. 14, 2034
Indication: Recurrent Vulvovaginal Candidiasis
Innovator: Mycovia Pharmaceuticals | Patent Expiry: Apr. 22, 2031
We combine decades of manufacturing excellence with cutting-edge R&D and global regulatory compliance.
Approved by U.S. FDA (9 audits), EU GMP (3 inspections), PMDA (Japan), and CEP certified. Our facilities meet the highest international standards.
Over 300 specialized technicians and state-of-the-art research facilities enable rapid development and scale-up of complex APIs and formulations.
300,000m² facility with annual capacity of 3,000+ tons of APIs and 8,000+ million tablets. Reliable supply for global partners.
Changzhou Pharmaceutical Factory (CPF) is established in Changzhou City, Jiangsu Province, China.
Our API, Hydrochlorothiazide, receives approval from the U.S. FDA – a major milestone in international compliance.
Received CEP (Certificate of Suitability) for Hydrochlorothiazide from the European Directorate for the Quality of Medicines.
Successfully passed 9 U.S. FDA audits and 3 EU GMP inspections – demonstrating consistent quality and compliance.
Changzhou Pharma and Nantong Chanyoo approved by U.S. FDA. Changzhou Wuxin approved under Chinese GMP.
Changzhou Pharma and Nantong Chanyoo successfully pass routine FDA inspections – reaffirming our commitment to quality.
We're ready to support your pharmaceutical sourcing needs with high-quality APIs and formulations.
Address: No. 518 Laodong East Road, Changzhou, Jiangsu, China
Phone: +86 519 88821493
Email: [email protected]
Email: [email protected]
Notice for Buyers: If you are a buyer, the above information is generated by AI collection and does not constitute any advice. If necessary, please visit the corresponding official website.
For Domain Owners: If you are the domain owner and do not want to be included by fobcompany.info, please contact [email protected] via your corporate email to cancel. We will cancel your inclusion within 3 business days.
如果您是域名所有者 不想被fobcompany.info收录 请用企业邮箱联系[email protected] 取消收录 我们将在3个工作日取消您的收录
Service Request: If you are other domain and want to be included, please contact [email protected]
如果您是其他域名合作 也请联系[email protected]